Why doesn't phase 3 of PP405 start straight away?
    Chat 12/19/2025

    At a glance
    In this general discussion post the tone is ๐Ÿ˜ neutral.

    Other terms

    Pelage is delaying the start of phase 3 trials for PP405 to 2026 due to necessary regulatory processes, despite having $120 million in funding. Users discuss the potential of PP405 for hair regrowth, with some expressing skepticism and others hopeful for new treatments like Breezula.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 487 results

      community July 1st - Early H2 - Breezula

      in Treatment  1 upvotes 9 months ago
      Discussion on hair loss treatments, focusing on Breezula, with mentions of Minoxidil, finasteride, RU58841, Pyrilutamide, GT20029, and PP405. Breezula's effectiveness is uncertain, with some trials showing minimal regrowth.

      community My summation of PP405 - looks promising

      in Research/Science  208 upvotes 1 year ago
      PP405 shows promise for hair regrowth by manipulating stem cell characteristics and lactate dehydrogenase, with Phase 2a trials pending. Google Ventures' $15M investment suggests confidence, but results and market availability remain uncertain.

      community PP405 Phase 2a press release with early results

      in Research/Science  693 upvotes 9 months ago
      PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.

    Related Research

    6 / 21 results